Lowenstein Sandler LLP acted as US counsel Edesa Biotech, Inc., Fasken Martineau DuMoulin, LLP, Canadian local counsel for the Company, Fenwick & West LLP, intellectual property...
Edesa Biotech Closes $25 Million Public Offering of Shares and Warrants
Processa Pharmaceuticals Acquires Vidya Therapeutics and Announces $200 Million Private Placement
Katten Muchin Rosenman has advised Processa Pharmaceuticals, Inc. Cooley has advised Vidya Therapeutics, Inc. Mintz has advised the placement agents. Processa Pharmaceuticals, Inc. (NASDAQ: PRCT) has...
CalciMedica Announces Private Placement of Up to $49 Million
Mintz has advised Guggenheim Securities as placement agent on the deal. CalciMedica, Inc., a clinical-stage biopharmaceutical company, has entered into a definitive securities purchase agreement for...
Rallybio to Acquire Avenzo Therapeutics and Complete $215 Million Private Placement
Cooley has advised Avenzo Therapeutics. Ropes & Gray has advised Rallybio Corporation. Mintz has advised the placement agents. Rallybio Corporation has entered into a definitive agreement...
Assembly Biosciences Completes $115 Million Registered Offering of Common Stock and Pre-Funded Warrants
Skadden has advised Assembly Biosciences. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has advised the underwriters. Assembly Biosciences, Inc. has announced the closing of its underwritten...
Avalo Therapeutics Launches $430 Million Public Offering of Common Stock and Warrants
Goodwin Procter LLP has advised Avalo Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a...
InflaRx Prices $150 Million Public Offering of Ordinary Shares
Kirkland & Ellis has advised InflaRx. Mintz has advised the underwriters. InflaRx N.V., a biopharmaceutical company focused on anti-inflammatory therapeutics, has announced the pricing of its...
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
Capricor Therapeutics Completes $172.5 Million Public Offering of Common Stock
Sidley Austin has advised Capricor Therapeutics. Mintz has advised the underwriters. Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company, has completed an underwritten public offering of...
Cogent Biosciences Announces $230 Million Convertible Senior Notes Offering
Gibson Dunn has represented Cogent Biosciences, Inc., and Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT) has announced the pricing of its underwritten public...
Cogent Biosciences Completes $345 Million Common Stock Offering and $200 Million Convertible Notes Offering
Gibson Dunn has represented Cogent Biosciences, Inc., Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for...
Verastem Oncology Prices $90 Million Public Offering
Ropes & Gray has advised Verastem Oncology. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Verastem Oncology (Nasdaq: VSTM) has announced the...